Cargando…
伴RUNX1突变髓系肿瘤42例临床特征和疗效分析
OBJECTIVE: To investigate the survival and prognostic factors of allogeneic hematopoietic stem-cell transplantation (allo-HSCT) for patients with myeloid neoplasms and RUNX1 mutations. METHODS: From July 2014 to April 2018, the clinical data of forty-two AML/MDS patients with RUNX1 mutations in the...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348223/ https://www.ncbi.nlm.nih.gov/pubmed/30612398 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.12.003 |